Form 4: Abbott Laboratories Executive Vice President Hubert L. Allen Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President Hubert L. Allen reports the disposition of Abbott Laboratories shares on February 29, 2024, and March 1, 2024.
Summary
- On February 29, 2024, Hubert L. Allen, an Executive Vice President at Abbott Laboratories, disposed of 8,214 common shares at a price of $120.05.
- Following this transaction, Allen directly owns 185,659 common shares.
- On March 1, 2024, Allen disposed of 853 common shares at a price of $118.5.
- Following this transaction, Allen directly owns 184,806 common shares.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel within Abbott Laboratories.
Stakeholder Impact
- The stock transactions may have a minor impact on shareholders, potentially influencing the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Disposition of 8,214 common shares at $120.05 per share. |
| 03/01/2024 | Disposition of 853 common shares at $118.5 per share. |
| 03/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.